Ombitasvir | Interleukin Related interleukin-related.com

Product Name :
Ombitasvir

Search keywords :
Ombitasvir

drugId :
null

Target Vo:
Nonstructural protein 5A

Target Vo Short Name :
NS5A

Moa_Name:
Nonstructural protein 5A inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Abbvie Inc

Active Company_Name :
Abbvie Inc

Active Indication_Name:
Hepatitis C, Chronic

In Active Indication_Name:
Hepatitis C

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Acetyl-p53 (Lys370) Antibody
STAT5 Antibody
CD4 Antibody: CD4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 51 kDa, targeting to CD4. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts